Delivery Order SPE2DB22D2218-SPE2DB23FR2FC
Award Date 4/28/23
Potential Completion Date 5/1/23
Potential Value $18K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This federal contract award, valued at $1,598.34, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order, with a Firm Fixed Price pricing type, and an ultimate completion date of October 30, 2024. The contract covers the supply of MYDAYIS ER 50 MG CAPSULE 100S, a pharmaceutical product, to support military healthcare programs. Amerisourcebergen holds a significant...
- This federal contract award, valued at $4,960.37, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to the prime contractor Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order under the company's existing Indefinite Delivery Contract (IDC) with the DLA, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for Amerisourcebergen to provide a comprehensive...
- This federal contract award is for the delivery of pharmaceutical products, specifically MYDAYIS ER 37.5 MG CAPSULE 100S, to the Defense Logistics Agency (DLA). The contract has a ceiling value of $2,971.74 and is a Firm Fixed Price Delivery Order. The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is not set aside and is an open competition award. Amerisourcebergen Drug Corp holds a larger Indefinite Delivery...
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp Corporate Office Division, a major pharmaceutical distributor. The $1,107.02 firm fixed price delivery order is for the supply of MYDAYIS ER 50 MG CAPSULE 100S, a prescription medication. This award is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999 through December 2025, which enables the DLA to efficiently procure a comprehensive...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,324.20 fixed-price delivery order is for the supply of the medication MYDAYIS ER 12.5 MG CAPSULE 100S, with a period of performance through March 2025. The award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical. This...
- This is a federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,037.41, is a delivery order (SPE2DX15D3017|SPE2DX24F0JKT) with the Defense Logistics Agency (DLA) Troop Support Medical, a defense agency. The contract is for the supply of MYDAYIS ER 50 MG CAPSULE 100S, a pharmaceutical product. This contract is not designated as a set-aside. AmerisourceBergen holds a significant Indefinite Delivery...
- This federal contract award is for the delivery of MYDAYIS ER 12.5 MG CAPSULE 100S, a pharmaceutical product, to the Defense Logistics Agency (DLA). The contract was awarded to the Amerisourcebergen Drug Corp Corporate Office Division, a major pharmaceutical distributor, on July 23, 2024 with a ceiling value of $1,659.92 and an ultimate completion date of July 24, 2024. The contract is a Delivery Order with a Firm Fixed Price pricing type. This award is not set-aside. Amerisourcebergen holds a...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $1,672.80 firm-fixed-price contract is for the supply of MYDAYIS CAPS 37.5MG, a prescription medication. The contract has an ultimate completion date of October 10, 2024. Amerisourcebergen, through its Corporate Office division, is a significant provider of pharmaceuticals and medical supplies to the U.S. federal...
- This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA). The contract, valued at $18,158.08, is a delivery order under the company's Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, worth up to $999,999,999.00. This IDC provides a comprehensive global pharmaceutical support vehicle to supply a wide range of pharmaceutical products and medical supplies to...
- AmerisourceBergen Drug Corp was awarded a delivery order on October 24, 2025, by the Defense Logistics Agency's Medical Supply Chain for the supply of MYDAYIS Capsules 50mg, a pharmaceutical product used in the treatment of attention deficit hyperactivity disorder. This non-set-aside, competitively awarded contract is valued at $4,246.35 and features firm fixed pricing with a delivery completion date of October 27, 2025. The place of performance is AmerisourceBergen's corporate office in...
- SPE2DB22D2218Indefinite Delivery Contract
- SPE2DB22D2218-SPE2DB23FR2FCDelivery Order
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA) and has a ceiling value of $18,164.59. The contract is a Delivery Order under an existing Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The specific award is for the drug MYDAYIS ER 50 MG CAPSULE 100S, with an ultimate completion date of May 1, 2023. The contract does not have a set-aside designation, indicating open competition.
Generated 5/9/25, 10:13 AM
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $18.2k | 4/28/23 |